Allogene Therapeutics, Inc. (ALLO) stock
ALLONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.74−0.06 (-7.79%)
Close on Nov 17, 2026Market cap $257.08MP/E –Yield 0.00%
Allogene Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Allogene Therapeutics's market cap was $310.85M on Nov 11, 2026, against $325.82M a year earlier. Over the last 5 years it ranged from $247.02M to $2.13B, with a median of $549.80M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $310.85M | +1.7% |
| 2025 | Dec 31, 2025 | $305.73M | -31.5% |
| 2024 | Dec 31, 2024 | $446.24M | -17.3% |
| 2023 | Dec 29, 2023 | $539.84M | -40.4% |
| 2022 | Dec 30, 2022 | $905.96M | -57.4% |
| 2021 | Dec 31, 2021 | $2.13B | -39.8% |
| 2020 | Dec 31, 2020 | $3.53B | +11.4% |
| 2019 | Dec 31, 2019 | $3.17B | +276.1% |
| 2018 | Dec 31, 2018 | $842.12M | – |
See a number that looks wrong?